Fresenius SE Income Taxes 2016-2024 | FSNUY

Fresenius SE annual/quarterly income taxes history and growth rate from 2016 to 2024. Income taxes can be defined as the total amount of income tax expense for the given period.
  • Fresenius SE income taxes for the quarter ending June 30, 2024 were $0.183B, a 13.01% decline year-over-year.
  • Fresenius SE income taxes for the twelve months ending June 30, 2024 were $0.459B, a 36.82% decline year-over-year.
  • Fresenius SE annual income taxes for 2023 were $0.516B, a 29.7% decline from 2022.
  • Fresenius SE annual income taxes for 2022 were $0.734B, a 25.49% decline from 2021.
  • Fresenius SE annual income taxes for 2021 were $0.986B, a 4.46% decline from 2020.
Fresenius SE Annual Income Taxes
(Millions of US $)
2023 $516
2022 $734
2021 $986
2020 $1,031
2019 $989
2018 $1,122
2017 $1,023
2016 $1,163
2015 $1,072
Fresenius SE Quarterly Income Taxes
(Millions of US $)
2024-06-30 $183
2024-03-31 $136
2023-12-31 $41
2023-09-30 $99
2023-06-30 $210
2023-03-31 $165
2022-12-31 $155
2022-09-30 $196
2022-06-30 $176
2022-03-31 $208
2021-12-31 $278
2021-09-30 $237
2021-06-30 $231
2021-03-31 $239
2020-12-31 $303
2020-09-30 $247
2020-06-30 $247
2020-03-31 $235
2019-12-31 $278
2019-09-30 $225
2019-06-30 $239
2019-03-31 $246
2018-12-31 $216
2018-09-30 $230
2018-06-30 $444
2018-03-31 $232
2017-12-31 $81
2017-09-30 $309
2017-06-30 $305
2017-03-31 $328
2016-12-31 $332
2016-09-30 $282
2016-06-30 $296
2016-03-31 $253
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $19.704B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00